Discover the THRIVE and GENIAL activities at EASL Liver Cancer Summit 2026
THRIVE ACTIVITIES AT EASL LIVER CANCER SUMMIT 2026 The overall aim of the THRIVE project is to improve the outcome of both paediatric and adult liver cancer patients by understanding at-risk…
Become part of the next generation of EASL’s leadership in 2026!
Are you deeply engaged in hepatology and science and ready to get involved in EASL’s governance? EASL is now looking to fill the following position: One Nurses & Allied Health Professionals (AHPs) Task Force Member…
On behalf of the European Health Alliance on Alcohol (EHHA), the European Association for the Study of the Liver (EASL) welcomes the European Parliament’s decision to safeguard consumers by endorsing clear and accurate “reduced-alcohol” labelling.
PRESS RELEASE 3 December 2025 On behalf of the European Health Alliance on Alcohol (EHHA), the European Association for the Study of the Liver (EASL) welcomes the European Parliament’s decision to safeguard…
DECISION – Project publishes fundamental study on immune mechanisms predicting outcomes in patients with ADC
The DECISION consortium has just published a fundamental study in the Journal of Hepatology on immune mechanisms predicting outcomes in patients with acutely decompensated cirrhosis (ADC). By analysing whole-blood RNA-sequencing (RNA-seq) data…
Implementation of submission fee for uninvited letters to the editor
In recent years, the Journal of Hepatology has witnessed a marked increase in the number of Letters to the Editor submitted for consideration. While we continue to value thoughtful academic dialogue and…
A tribute to Prof. Stephanos J Hadziyannis
EASL mourns the passing of Professor Stephanos J Hadziyannis, who died peacefully on Monday 17 November. His loss is deeply felt across the hepatology community, where he was regarded as a visionary…
Liver transplantation utilising grafts donated after medical assistance in dying is feasible and has outcomes comparable to standard donation
NEWS RELEASE UNDER EMBARGO UNTIL OCTOBER 27, 2025, 00:01 ET (12:01 AM ET) Media contact: Freya Weise, MD, PhD Elsevier +33 (1) 71 16 55 00 hmsmedia@elsevier.com
